ApoB and Resilient Cost-Effectiveness of Statin Intensity

Statin therapy is the medical workhorse of primary atherosclerotic cardiovascular disease (ASCVD) prevention. At generic prices, statins are effective, low-cost, and relatively safe medical options for individuals at high or intermediate risk for ASCVD, with the potential of being cost-effective at very low levels of ASCVD risk. There has been less consensus regarding how to intensify statin therapy based on treatment targets, such as using low-density lipoprotein cholesterol (LDL-C), non–high-d...